The shift towards minimally invasive methodology is driving the use of surgical stents. Stents are fundamental parts in different minimally invasive medical procedures, offering advantages, for example, decreased convalescence times, lower post-usable difficulties, and more limited emergency clinic stays. This pattern is adding to the expanding use of stents in various clinical fields.
The rise of biodegradable and bioresorbable stents addresses a critical pattern in the market. These stents are intended to break up over the long haul, diminishing the drawn-out presence of unfamiliar material in the body continuously. This innovation tends to worries connected with difficulties related with permanent stents.
The maturing worldwide population is a segment pattern impacting the surgical stents market. As people age, the risk of cardiovascular infections and other ailments requiring stent arrangement increments. The market is answering the developing medical services needs of the elderly by creating stents that take care of the difficulties in this segment.
Drug-eluting stents, which discharge meds to forestall restenosis and aggravation, have become standard in certain interventional methodology. The market is seeing a proceeded with take-up of DES, with progressing research zeroing in on improving drug conveyance frameworks to improve their viability and security.
The pattern towards customized medication is affecting the advancement of modified stent arrangements. Fitting stents to individual patient attributes, like vessel life structures and hereditary elements, is acquiring consideration. This customized approach expects to further develop treatment results and limit unfavorable occasions.
The pattern towards short term strategies is affecting the surgical stents market. Stent implantation strategies that can be acted in short term settings offer benefits like expense adequacy and accommodation for the two patients and medical care suppliers. This shift lines up with more extensive medical services patterns underlining wandering consideration and diminishing hospitalization rates.
Surgical Stents Market Size was valued at USD 11.57 Billion in 2023. The Surgical Stents industry is projected to grow from USD 12.19 Billion in 2024 to USD 21.56 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.93% during the forecast period (2024 - 2032). The stent is a small, flexible metal or plastic tube that are inserted into the vessels or duct to keep the passageway open. Different types of materials like metal, standard polymer, and biodegradable polymer are used for the preparation of the surgical stents. According to the WHO (2015), more than 35% of the total global population was suffering from major or minor cardiovascular complications; and in 2014, globally 39% of adults aged 18 years and over were overweight whereas, 13% were obese. Thus, increasing prevalence of diabetes and obesity have increased the risk of urinary tract failure.
Major driving factors for the growth of the market: Increasing prevalence of cardiovascular diseases, rising diabetic & obese population and rapid development in the technology. Moreover, rising healthcare expenditure, increasing geriatric population, and changing lifestyle have fueled the growth of the market. However, higher cost of surgeries and risk of infection may hinder the growth of the market during the forecast period 2017-2013.
Study Objectives:
Intended Audience
Figure 1- Surgical Stents Market, By Application, 2016 (%)
Source- Annual reports, press release, white paper, company presentation
Some of the major key player for the market are
The surgical stents market is segmented into types, type of materials, application, and end users. On the basis of types, the surgical stents market is segmented: cardiac stents, urinary stents, biliary stents, esophageal stents, prostatic stents and other. Cardiac stents are further segmented: self-expanding stents, balloon expanding stents, bio-engineered stents, dual therapy stents, artery stents, drug eluting stents and other. Urinary stents are further segmented: open end stents, double pigtail stents, closed end stents and multi loop stents. On the basis of materials, the market is segmented: metal, standard polymer, and biodegradable polymer. On the basis of applications, the market is segmented into cardiac diseases, urinary tract diseases, and others. On the basis of end users, the market is segmented into hospital, clinics, and others.
America dominates the surgical stents market owing to an enormous number of the patient suffering from cardiac and renal diseases. Additionally, well-developed healthcare sector and higher healthcare expenditure have supported the growth of the market in this region. Europe accounts for the second largest market followed by Asia Pacific. Asia Pacific is the fastest growing region in the surgical stents market due to the presence of huge patient population base and rapidly developing economies.
Market Assessment
Source- World Health Organization (WHO), white paper, company presentation, American Heart Association, National Institutes of Health, The National Institute of Diabetes and Digestive and Kidney Diseases, Centres for Disease Control and Prevention, Annual reports
The report for the surgical stents market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected Surgical Stents Market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)